News Medical

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ® ULTRA ...
The Financial

JUVÉDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids

The FINANCIAL — Allergan plc, on June 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA XC, for use in the lips for lip ...
Business Wire

ADDING MULTIMEDIA FDA Approves JUVÉDERM VOLUMA™ XC

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
The Financial

U.S. FDA Approves JUVEDERM ULTRA XC for Use in Lips

The FINANCIAL — Allergan plc, on October 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ULTRA XC for injection into the lips and ...